SR Bio-Tech focuses on the preparation and capture of engineered extracellular vesicles (EVs), multi-omics detection, and data analysis of EV sources, as well as cell-targeted drug delivery.The company's core technologies include nucleic acid and protein detection kits for EVs derived from tumor cells, core products such as anti-tumor protein drugs, and monoclonal antibodies for new immunotherapy targets. The core vision is to provide optimal diagnosis and treatment solutions for cancer patients. Since its establishment, the company has collaborated with dozens of top-tier hospitals in China, playing a key role in more than ten national and provincial-level key science and technology innovation projects and basic research projects, with a total approved funding exceeding tens of millions.